Copyright
©The Author(s) 2015.
World J Hepatol. Apr 28, 2015; 7(6): 859-873
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.859
Published online Apr 28, 2015. doi: 10.4254/wjh.v7.i6.859
Figure 1 Potential outcomes of gene therapy.
A: Correction of mutations or augmentation of gene function by introduction of a second copy of the gene of interest into a safe harbor locus; B: Changes to transcriptional regulation of a gene of interest, allowing for correction of gene function either by transcriptional activation or suppression. The grey boxes represent exons and linking lines represent introns.
- Citation: Nicholson SA, Moyo B, Arbuthnot PB. Progress and prospects of engineered sequence-specific DNA modulating technologies for the management of liver diseases. World J Hepatol 2015; 7(6): 859-873
- URL: https://www.wjgnet.com/1948-5182/full/v7/i6/859.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i6.859